Disposable Syringe Markets

The report examines the disposable syringe market. It provides detailed forecasts for the traditional and safetyengineered sharps markets. It describes the major drivers and restraints, technology trends, and industry challenges for the disposable syringe market. It examines the markets for blood collection sets, hypodermic access syringes and needles, sharps-based insulin delivery devices, and other specialty syringes and needles. Additionally, the study considers the disposable syringe supplies utilized in clinics and by patients in their homes to diagnose and monitor diseases, as well as to administer medications. This analysis is intended to provide basic market data pertaining to the U.S. and worldwide market segments. Each market segment is analyzed to determine size, growth rates, sales projections and factors influencing growth in the U.S. and internationally. Unit and dollar volumes have been used to indicate market sizes.

The study specifically focuses on market dynamics, current market drivers and emerging trends within the disposable syringe markets. Additionally, this review examines industry challenges and potential threats to syringe and needle supply manufacturers. The emphasis is on those companies actively developing and marketing products to hospitals, physicians and the public for medically-related uses. The reader should consult other TriMark

The market segments for disposable syringes are:

- Prefilled syringes.
- Safety syringes.
- Insulin injector pens.
- Needleless injectors.
- Vaccination injectors.
- Blood collection needles and syringes.
- Hypodermic needles and syringes.
- Insulin needles and syringes.
- Specialty needles and syringes.

This analysis provides an overview of individual disposable syringe market segments, some of which possess the elements that will lead to high and sustained growth rates for the near future. The report also presents a description of the ancillary supplies marketed by major companies in each market segment. The study presents qualitative and quantitative data, and information on key market measures and benchmarks such as:

- Market size by segment.
- Company market share.
- Product market share.
- Technology market share.
- Industry structure.
- Economic factors.
- Syringe design criteria.
- Product pricing.
- Emerging markets.
- Market projections.
- Strategic alliances.
- Proprietary technology.
- Technology factors.
- Market factors.
- Regulatory factors.

Technology areas include:

- Auto-Disable/Single-use Syringes: Syringes that deactivate after one use and are especially useful for vaccinations in developing countries.
- Blood Collection Syringes and Needles: Winged and standard phlebotomy access devices.
- Retractable Syringes: In retractable syringes, the needles retract into the syringe barrel after use, so the barrel acts as the sharps container.
- Needleless Injectors: Injection devices that deliver the pharmaceutical through the skin without the use of a needle.
- Autoinjector Pens: In autoinjector pens, syringe automatically triggers to insert the needle to deliver the pharmaceutical.

This report does not cover peripheral devices such as lancing devices for patients with diabetes. Moreover, it does not discuss non-syringe devices such as breast examination kits, temperature-measuring devices, fertility control devices, condoms, gels or creams. This review, furthermore, does not cover disposable plastic supplies for the healthcare market unless the products designed specifically for use and sale in one of the designated market segments covered in this report.

A number of companies that market syringe products are primarily distributors of these products, rather than the primary developer. These companies—necessary and important to the medical products industry—are covered here to a limited degree. Concentration is placed on the disposable medical supplies market segment in important worldwide markets such as the U.S., Japan and Europe. It focuses primarily on the hospital market segment, and, separately, on a description of the devices and supplies marketed by major companies in this segment for home use. Additionally, the report focuses on the vaccine segment of the disposable syringe market, and its growth in developing countries.

Objectives

The primary objectives of this study are to:

- Identify important market drivers through a comprehensive look at various sales segments for disposable syringes.
- Obtain a complete understanding of the structure of the disposable syringe business from its basic principles to its applications.
- Discover feasible market opportunities by identifying high-growth applications in different medical areas, with a focus on the biggest and expanding markets.
- Focus on global industry developments through an in-depth analysis of the major world markets for disposable syringe supplies, including forecasts for growth.
- Define the disposable syringe market including definitions, processes and trends.
- Assess the market drivers and bottlenecks, from the perspective of the medical and commercial communities.
- Discuss the potential benefits of disposable syringes for various sectors of the medical and commercial communities.
- Establish the current total market size and future growth of the disposable syringe market, and analyze the current size and growth of individual segments.
- Provide current and forecasted market shares by company.
- Discuss profit and business opportunities by individual market segment.
- Provide strategic recommendations for near-term business opportunities.
- Assess current commercial uses of disposable syringes.
- Assess the disposable syringe business model.
- Analyze and evaluate safety syringe products, and assess the market potential for existing and probable future products.
- Analyze product designs, technologies and marketing challenges of syringe manufacturers.
- Provide detailed descriptions of segments in safety syringe market, market demographics and business strategies.
- Chart product sales data, market share and forecasts.
- Profile safety syringe companies, noting their product development activities, business strategies, and corporate alliances and affiliations.

This report answers the following questions:

- What are the near term business opportunities in disposable syringes?
- What are the current and forecasted sizes of the disposable syringe market?
- What are the business models currently used by companies in disposable syringe market?
- What are the technologies used in disposable syringe supplies?
- Who holds the proprietary rights to disposable syringe technology?
- What regulatory processes must disposable syringes undergo in the U.S., Japan and Europe?
- How will technology changes in disposable syringes affect treatment and payment paradigms?
- How will litigation concerns increase physician and hospital use of disposables?
- How will technology reduce adverse growth trends and decrease total patient care cost? SHOW LESS READ MORE >

1. Introduction
1.1 Statement of Report
1.2 About This Report
1.2.1 Scope of the Report
1.2.2 Objectives
1.2.3 Methodology
1.3 Executive Summary

2. Syringe Types: An Overview
2.1 Disposable Syringes
2.2 Safety Syringes
2.2.1 Available Safety Syringe Technologies
2.2.2 Retrofitted Syringes
2.2.3 Automatically Retractable Syringes
2.2.4 Manually Retractable Syringes
2.2.5 Insulin Syringes
2.2.6 Tuberculin Syringes
2.2.7 Prefilled Syringes
2.2.7.1 Components of a Prefilled Syringe
2.2.7.2 Benefits of Prefills
2.2.7.3 Prefills: The Future of Drug Delivery
2.2.7.4 Wider Applications of Prefilled Syringes
2.2.7.5 Making Improvements in Components of Prefilled Syringes
2.2.7.6 Biologic Drugs and Overfill
2.2.7.7 Benefits of Cyclic Olefin Polymers
2.2.7.8 Overcoming Variability in Glass Syringes
2.2.7.9 Impact of Silicone Oil on Delivery
2.2.7.10 Migrating Risk for Protein Aggregation
2.2.7.11 Key Advantages of Prefilled Syringes
2.2.8 Production of Standard Prefilled Syringes
2.2.8.1 Attachment of Safety Features in Prefilled Syringes
2.2.9 Available Prefilled Syringes in the Market
2.2.9.1 Baxter Biopharma Solutions
2.2.9.2 BD Medical's Prefilled Segment
2.2.9.3 Catalent Pharma Solutions
2.2.9.4 Cook Pharma's Filling and Packaging
2.2.9.5 Gerresheimer AG's Syringe Designs
2.2.9.6 Unilife Corporation's New Approach
2.2.9.7 West Pharmaceutical Services, Inc.'s Prefilled Syringes
2.3 Pen Injectors
2.3.1 Insulin Pens
2.3.2 Buyer's Guide for Reusable Insulin Pens
2.3.2.1 Technical Considerations for Insulin Pens
2.3.2.2 Technical Considerations for Insulin Cartridges
2.3.2.3 Technical Considerations for Pen Needles
2.3.2.4 Device Considerations
2.3.2.5 User Considerations
2.3.3 Market Review of Selected Insulin Pens
2.3.3.1 Autopen 24 and Autopen Classic from Owen Mumford
2.3.3.2 Humapen Luxura and Luxura HD from Eli Lilly
2.3.3.3 Humapen Memoir from Eli Lilly
2.3.3.4 Novopen 3 and Novopen Junior/Demi from Novo Nordisk
2.3.3.5 OptiClick from Sanofi-Aventis
2.3.3.6 OptiPen Pro from Sanofi-Aventis
2.4 Advanced Injection Devices
2.4.1 Insulin Delivery Device Technology
2.4.2 Biologic Delivery Device Technology
2.4.3 Alternative Delivery Technologies
2.5 Needle-free Injectors
2.5.1 Needleless Injector from Injex
2.5.2 Jet Syringes from Injex
2.5.3 Syrijet
2.5.4 PenJet
2.5.5 Needle-free Injector for Human Growth Hormones

3. Award Winning Syringes
3.1 Episure AutoDetect Syringe
3.2 ConfiDose
3.3 Humatrope Reconstitution Devices
3.4 Vascez Plungerless Syringe
3.5 PowrSyringe injector
3.6 NovoFine Autocover Automatic Safety Pen Needle
3.7 RevVac Auto-Retractable Vacuum Safety Syringe

4. Syringe Industry: Overview
4.1 Common Diseases Transmitted by Unsafe Needle Use and Needlesticks
4.2 Most Common Instances of Needstick Injuries
4.3 Needle Phobia and Patients' Anxieties
4.4 Global Transition to Safety Medical Devices
4.5 U.S. Regulation
4.6 Worldwide Regulation
4.7 Enforcing Compliance with Sharps Safety Legislation
4.8 Example of an OSHA Violation
4.9 Target Market Awaiting Premium Products
4.10 Current Types of Safety Syringes
4.10.1 Safety Syringes with a Needlestick Protection Device
4.10.2 Needle Guard
4.10.3 Needle Sheath
4.10.4 Retractable Syringes
4.10.4.1 Spring Based Non-Controlled Retracting Needle Syringe
4.11 Global Need for Safety Syringe Products
4.12 Limitations of Existing Clinical Syringes
4.13 Limitations of Existing Prefilled Syringes
4.14 Market Expansion for Safety Syringes
4.15 Technological Advancements in Disposable Syringes
4.16 Reconstitution inside Sterile Syringes
4.16.1 Vetter Lyo-Ject
4.17 Plungerless Prefilled Syringes
4.18 The Disposable UniJect
4.19 Needle-free Injection

5. Disposable Syringes: Market Analysis
5.1 Volume of Syringes Used in Healthcare
5.2 Syringe Sizes Required for Injectable Drugs
5.3 Domination of Syringes in Parenteral Drug Delivery Market
5.4 Global Market for Disposable Syringes
5.4.1 Global Market for Disposable Syringes by Product Segmentation
5.4.2 Global Market for Safety Syringes by Segmentation
5.4.3 Combined Market for Injection Devices
5.5 U.S. Market for Hypodermic Safety Syringes
5.5.1 Disposable Syringes: U.S. Market Segments
5.5.2 Types of Safety Syringes Used in U.S. Hospitals
5.5.3 U.S. Market for Safety Syringes
5.5.4 Competitive Landscape in the U.S.
5.5.5 Price of Safety Syringes in the U.S.
5.5.6 U.S. Disposable Syringe Market
5.5.7 U.S. Safety Syringe Market
5.6 European Market for Disposable Syringes
5.6.1 European Market for Safety Syringes
5.7 Prefill Market Trends
5.8 The Shift from Vials to Prefilled Syringes
5.9 Prefilled Syringes: Market Dynamics
5.10 Importance of Prefilled Syringes to Extend Brand Life
5.11 Biggest Markets for Prefilled Syringes
5.12 Dealing with the Latest Trends in Prefilled Syringe Market
5.13 Market Opportunities for Prefilled Syringes
5.14 Pharmaceutical Share of Key Prefilled Therapeutic Market
5.15 Specialty Pipeline Drugs Targeted for Use with Prefilled Syringes
5.16 Therapeutic Usage of Prefilled Syringes
5.16.1 Anti-Infectives in Prefilled Syringes
5.16.2 Cardiovascular Drugs in Prefilled Syringes
5.16.3 Central Nervous System Drugs in Prefilled Syringes
5.16.4 Hematology Drugs in Prefilled Syringes
5.16.5 Human Growth Hormones in Prefilled Syringes
5.16.6 Musculoskeletal Drugs in Prefilled Syringes
5.16.7 Obsterics Drugs in Prefilled Syringes
5.16.8 Oncology Drugs in Prefilled Syringes
5.16.9 Vaccines in Prefilled Syringes
5.17 Flexible Administration Requirements of Prefilled Syringes
5.18 Biotech Blockbusters Available in Prefilled Syringes
5.19 Selected Drugs Available in Prefilled Syringes
5.19.1 Ovidrel
5.19.2 Enbrell Prefilled Syringe
5.19.3 Biocon's Prefilled Safety Syringes
5.19.4 PEGASYS
5.19.5 Afluria
5.19.6 Enzira
5.19.7 FluZone Vaccine
5.19.8 Novolin
5.19.9 NovoLog
5.19.10 Glaxo SmithKline's Vaccines in Prefilled Syringes
5.20 Selected Providers of Syringe Prefilling Services and Products
5.20.1 Althea Technologies, Inc.
5.20.1.1 Althea's Clinical Manufacturing
5.20.1.2 Althea's Fill/Finish Services
5.20.1.3 Althea's Contract Manufacturing
5.20.2 Baxter International, Inc.
5.20.2.1 Baxter's Contract Manufacturing
5.20.2.2 Baxter's Fill/Finish Services
5.20.2.3 Baxter's Prefilled Syringes Capability
5.20.2.4 Baxter's Vials
5.20.2.5 Baxter's Cartridges
5.20.3 Becton Dickinson and Company
5.20.3.1 BD's Prefilled Syringe Services
5.20.3.2 BD Hypak SCF Glass Prefillable Syringes
5.20.3.3 BD Sterifill SCF Plastic Prefillable Syringe Systems
5.20.3.4 BD Physioject Disposable AutoInjector
5.20.3.5 BD Liquid Dry Disposable Pen Injector
5.20.3.6 BD Pens Customized Self-Injection Systems
5.20.3.7 BD Soluvia Prefillable Microinjection System
5.20.4 Catalent Pharma Solutions, Inc.
5.20.5 Hyaluron Contract Manufacturing
5.20.5.1 Hyaluron's Syringe Filling
5.20.5.2 Vetter Pharma Fertigung GmbH
5.20.5.3 Vetter's Development Service
5.20.5.4 Vetter's Commercial Manufacturing
5.21 Global Market for Prefilled Syringes
5.21.1 Steady Growth in Consumption of Prefilled Syringe Units
5.22 U.S. Market for Prefilled Syringes
5.23 Rapid Adoption of Prefilled Syringes for Injectables
5.24 Pharmaceutical Consumption of Prefilled Syringes
5.25 Market for Pharmaceutical Prefilled Syringes
5.25.1 Global Market for Prefilled Pain Management Drugs
5.25.2 Global Sales of Enbrel in Prefilled Syringes
5.25.3 Global Market for Prefilled Psoriasis Drugs
5.25.4 Global Market for Prefilled Anemia Drugs
5.25.5 Global Market for Prefilled Disposable Insulin Delivery Devices
5.25.6 Global Market for Insulin in Prefilled Devices
5.25.7 Global Market for Oncology Drugs in Prefilled Syringes
5.25.8 Global Market for Multiple Sclerosis (MS) Drugs in Prefilled Syringes
5.25.8.1 Market Leaders in Multiple Sclerosis Drugs in Prefilled Syringes
5.25.9 Global Market for Prefilled Arthritis Drugs
5.25.10 Global Market for Vaccines in Prefilled Syringes
5.25.10.1 Market Leaders in Injectable Vaccines
5.25.11 Market Leaders in Injectable Anticoagulants
5.25.12 Market Leaders in Injectable Anti-Inflammatory Drugs
5.25.13 Market Leaders in Injectable Hematology Drugs
5.25.14 Market Leaders in Injectable Obstetrics Drugs
5.26 Insulin Pens: Market Analysis
5.26.1 Disposable Insulin Pens
5.26.2 Refillable Pens
5.26.3 Pen Needles
5.26.4 Benefits and Patient Preferences of Insulin Pens
5.26.5 Disadvantages of Pen Syringes
5.26.6 Insulin Pens and Hospital Bills
5.26.7 Market for Insulin Pen
5.27 Global Market for Auto-Injectors/Auto-Infusors
5.27.1 U.S. Leaders in Insulin Pump Market
5.28 The Growth Market for Self-Injection

6. Global Market for Conventional Injectables
6.1 Global Market for Drug Delivery Devices
6.2 Evolving Trends in Insulin Delivery
6.2.1 Alternative Modes of Insulin Delivery
6.2.2 Insulin Injection Ports
6.2.3 Continuous Subcutaneous Insulin Infusion Pumps
6.2.4 Transdermal Patches
6.2.5 Inhalable Insulin Devices
6.3 Global Burden of Diabetes
6.3.1 Market for Insulin Delivery Devices
6.3.2 Leaders in Insulin Delivery Devices
6.4 Global Insulin Consumption
6.4.1 Market Growth for Insulin by Type
6.4.2 Market Growth for Modern Insulin Delivery Systems
6.4.3 Market Leaders in Insulin by Value
6.4.4 Global Insulin Volume Share
6.4.5 Diabetes Care in the U.S. by Treatment Class
6.4.6 Insulin Types Used in the U.S.
6.4.7 Types of Incretin Used in the U.S.
6.4.8 Five-Year Growth for OAD, Insulin and GLP-1
6.4.9 Five-Year Growth for Long Acting, Premix and Fast Acting Insulins in the U.S., 2006-2011
6.4.10 U.S. Insulin Market
6.4.11 Modern Insulin and Modern Device Penetration in the U.S. Market
6.4.12 Leaders in U.S. Insulin Market
6.4.13 U.S. Insulin Value Market Share by Company
6.4.14 U.S. Short-Acting Insulin Market Share
6.4.15 U.S. Premix Insulin Market
6.4.16 U.S. Long-Acting Insulin Market
6.4.17 European Diabetes Care Market
6.5 European Market Leaders in Diabetes Care
6.5.1 Percent Diabetics in Europe Using TDZ, DPP-IV, GLP-1 and Insulin
6.5.2 European Insulin Market by Segment
6.5.3 European Modern Insulin Market Share by Company
6.6 Chinese Diabetes Care Market by Treatment Class
6.6.1 Companies Active in Chinese Diabetes Care Market
6.6.2 Chinese Insulin Market by Segment

7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott's Syringe Products
7.1.1.1 Precision Sure-Dose Syringes
7.1.1.2 Humira Prefilled Syringe
7.1.1.3 Humira Pen
7.2 Albert David Limited
7.3 Alshifa Medical Syringes Manufacturing Company Ltd.
7.4 Althea Technologies, Inc.
7.5 Baxter International, Inc.
7.5.1 Baxter's Anesthesia Business
7.5.2 Baxter's Clinical Nutrition Business
7.5.3 Baxter's Hemophilia Therapies
7.5.4 Baxter's Infusion Systems
7.5.5 Baxter's Pharmaceuticals and IV Solutions
7.5.6 Baxter's Renal Products
7.5.7 Baxter's Business Performance
7.6 Becton, Dickinson & Co.
7.6.1 BD's International Operations
7.6.2 BD Medical
7.6.3 BD Diagnostics
7.6.4 BD Biosciences
7.6.5 BD's Geographic Performance, 2011
7.6.6 BD's Role in Designing Devices for Safe and Effective Injections and Infusions
7.6.6.1 BD's Safety-Engineered Devices
7.6.6.2 BD Auto-Disable Syringes
7.6.6.3 BD's Insulin Syringes
7.6.6.4 BD's Allergy Syringes
7.6.6.5 BD's Tuberculin Syringes
7.6.6.6 BD's Syringes and Needles
7.6.6.7 BD's Safety-Lok Safety-Syringes
7.6.6.8 BD's Safety Glide Syringes
7.6.6.9 BD's Eclipse Needles
7.6.6.10 BD's Integra Syringes
7.6.6.11 BD's PosiFlush Prefilled Syringes
7.7 B. Braun
7.7.1 B. Braun's Hospital Care Division
7.7.2 B. Braun's Aesculap Division
7.7.3 B. Braun's Out-Patient Market (OPM) Division
7.7.4 B. Braun's Avitum Division
7.7.5 B. Braun's Overall Business Performance
7.7.6 Hospital Care Division's Business
7.7.7 Aesculap Division's Business
7.7.8 OPM Division's Business
7.7.9 Avitum Division's Business
7.7.10 B. Braun's Syringe Products
7.7.10.1 Sterican Insulin Needle
7.7.10.2 Omnifix 100 Duo
7.7.10.3 Omnifix 100 Solo
7.7.10.4 Inject 40 Duo
7.7.10.5 Injekt 40 Solo
7.7.10.6 Omnifix 40 Duo
7.7.10.7 Omnifix 40 Solo
7.7.10.8 Omnican 100
7.7.10.9 Omnican 50
7.7.10.10 Omnican 20
7.7.10.11 Omnican 40
7.7.10.12 Omnican Pen
7.7.10.13 Omnican Fine
7.8 Bioject Medical Technologies, Inc.
7.8.1 Bioject's Technology
7.8.2 Bioject's Products
7.8.2.1 Biojector 2000
7.8.2.2 Bioject's Drug Reconstitution System
7.8.2.3 Vitajet
7.8.2.4 ZetaJet
7.9 Catalent Pharma Solutions, Inc.
7.9.1 Catalent's Development and Clinical Services Segment
7.9.2 Catalent's Oral Technologies Segment
7.9.3 Catalent's Sterile Technologies Segment
7.9.4 Catalent's Packaging Services Segment
7.9.5 Catalent's Syringe Solutions
7.10 C.R. Bard, Inc.
7.10.1 Bard's Vascular Business
7.10.2 Bard's Urology Business
7.10.3 Bard's Oncology Business
7.10.4 Bard's Surgical Specialties Business
7.10.5 Bard's Syringe Products
7.10.5.1 Bard's Piston Syringes
7.10.5.2 Bard's Bulb Syringes
7.11 Coeur, Inc.
7.11.1 Angiographic Syringes from Coeur
7.11.2 CT Syringes from Coeur
7.12 Covidien Ltd.
7.12.1 Covidien's Medical Device Segment
7.12.2 Covidien's Pharmaceutical Segment
7.12.3 Covidien's Medical Supplies Segment
7.12.4 Covidien's Syringes and Needles
7.12.4.1 Magellan Safety Needles
7.12.4.2 Magellan Safety Needle and Syringe Combination
7.12.4.3 Magellan Insulin Safety Syringe
7.12.4.4 Magellan Tuberculin Safety Syringe
7.12.4.5 Magellan Safety Blood Collection Device
7.12.4.6 Monoject Insulin Safety Syringe
7.12.4.7 Monoject Tuberculin Safety Syringe
7.12.4.8 Monoject 3mL Safety Syringe
7.12.4.9 Monoject 6mL Safety Syringe
7.12.4.10 Monoject 12mL Safety Syringe
7.12.4.11 SoftPack Hypodermic Needles
7.12.4.12 Rigid Pack Hypodermic Needles
7.12.4.13 Rigid Blunt Cannulas
7.12.4.14 Soft Pack Tuberculin Syringes
7.12.4.15 Rigid Pack Tuberculin Syringes
7.12.4.16 SoftPack Insulin Syringes
7.12.4.17 Rigid Pack Insulin Syringes
7.12.4.18 Allergy Trays with Permanently Attached Needles
7.13 Henke-Sass, Wolf GmbH
7.13.1 Selected Products from Henke-Sass
7.13.1.1 Two-Part Disposable Syringes 1-50 mL
7.13.1.2 Three-Part Disposable Syringes 1-30 mL
7.13.1.3 Disposable Needles HSW FINE-JECT
7.14 Hindustan Syringes & Medical Devices Ltd. (HMD)
7.14.1 Insulin Syringes from HMD
7.14.2 HMD's Single-Use Needles
7.14.3 HMD's Single-Use Syringes
7.15 Hi-Tech Medical Products Ltd.
7.16 Hyaluron Contract Manufacturing (HCM)
7.16.1 HCM's Major Markets
7.16.2 HCM's Facility
7.16.2.1 Inova SV-122 Syringe Filler
7.16.2.2 Inova H3-5V Syringe Filler
7.16.2.3 Inova VFVM-3031 Vial Filler
7.17 International Medication System Ltd.
7.17.1 Delivery Systems from IMS
7.17.2 PCA Products from IMS
7.17.3 Phtonadione Injection USP
7.17.4 Lidocaine HCL Jelly, USP 2%
7.18 Life-Shield Products, Inc.
7.19 MedPro Safety Products, Inc.
7.19.1 MedPro's Targeted Markets
7.19.2 MedPro's Products
7.19.2.1 Blood Collection Safety Needle
7.19.2.2 Winged Safety Blood Collection Set
7.19.2.3 Safety Syringe with Anti-blunting Feature
7.19.2.4 Prefilled Safety Syringes
7.19.2.5 Key-Lok Needleless IV Systems
7.20 Merit Medical Systems, Inc.
7.20.1 Merit's Inflation Devices
7.20.2 Merit's Hemostasis Valves
7.20.3 Merit's Vascular Access Products
7.20.4 Merit's Diagnostic Catheters, Guide Wires and Torque Devices
7.20.5 Merit's Angiography and Accessories
7.20.6 Merit's Safety and Waste Management Systems
7.20.7 Merits Obesity Products
7.20.8 Merit's Drainage Catheters and Accessories
7.20.9 Merit's Parentesis and Pericardiocentesis Catheters
7.20.10 Merit's Therapeutic Infusion Catheters
7.20.11 Merit's Dialysis and Interventional Nephrology Products
7.20.12 Coronary Control Syringes
7.20.13 Medallion Syringes
7.20.14 RXP Syringe
7.20.15 VacLok Syringes
7.20.16 Merit's Manufacturing Facilities
7.21 Milestone Scientific
7.21.1 Milestone Scientific's Product Platform
7.21.1.1 STA Single Tooth Anesthesia System (STA System)
7.21.1.2 CompuDent
7.21.1.3 CompuMed
7.21.1.4 The Wand
7.21.1.5 The SafetyWand
7.22 Novo Nordisk A/S
7.22.1 Novo Nordisk's Global Diabetes Care Business
7.22.1.1 Novo Nordisk's Diabetes Care Business in North America
7.22.1.2 Novo Nordisk's Diabetes Care Business in Europe
7.22.1.3 Novo Nordisk's International Business in Diabetes Care
7.22.1.4 Novo Nordisk's Diabetes Care Business in Japan and Korea
7.22.1.5 Insulin Pens and Needles from Novo Nordisk
7.22.2 Pipeline Progress in Novo Nordisk
7.22.3 Novo Nordisk's Modern Insulin Portfolio
7.23 Owen Mumford Ltd.
7.23.1 Autopen
7.23.2 Autoject 2
7.23.3 Unifine Pentips
7.23.4 UniGuard
7.24 Plas-Pak Industries, Inc.
7.24.1 Disposable Veterinary Syringes
7.24.2 Dual Syringe and Dental Syringe from Plas-Pak
7.24.3 Manual Dual Syringes
7.25 Retractable Technologies, Inc.
7.25.1 Retractable Technologies' VanishPoint Products
7.26 Revolutions Medical Corporation
7.26.1 RevVac Safety Syringe
7.27 Safety Syringes, Inc.
7.27.1 UltraSafe Needle Guards
7.27.2 UltraSafe Passive Needle Guard
7.27.3 UltraSafe Passive Needle Guards for Luer Lock and Luer Slip Syringe
7.27.4 UltraSafe Automated Assembly
7.27.5 UltraSafe Product Development
7.28 Smiths Medical International/Medex, Inc.
7.28.1 Smiths Medical's Markets
7.28.1.1 Smiths' Medication Delivery Segment
7.28.1.2 Smiths' Vital Care Segment
7.28.1.3 Smiths' Safety Segment
7.28.2 Syringes from Smiths
7.28.2.1 Hypodermic Needle-Pro Fixed Needle TB Syringe
7.28.2.2 Hypodermic Needle-Pro Device
7.28.2.3 Hypodermic Needle-Pro Device and Syringe
7.28.2.4 Hypodermic Needle-Pro Device for Insulin Injections
7.28.2.5 Hypodermic Needle-Pro Fixed Needle Insulin Syringe
7.29 Star Syringe Ltd.
7.29.1 Star Syringe' Alliances
7.29.2 Star Syringe Products
7.29.2.1 K Safety Technology: K1 Auto-disable Syringe Mechanism
7.29.2.2 K3 Safety Cap
7.29.2.3 K5 Aspiration
7.30 Terumo Medical Corporation
7.30.1 Terumo's Syringe Products
7.30.1.1 SurGuard2 Syringes with Safety Needle
7.30.1.2 SurGuard2 Safety Needles
7.30.1.3 Terumo Hypodermic Needles
7.30.1.4 Terumo Hypodermic Syringes without Needle
7.30.1.5 Terumo Tuberculin Syringes
7.30.1.6 Terumo Hypodermic Syringes with Needle
7.30.1.7 SurSaver 1CC Syringes with Low Dead Space
7.30.1.8 Terumo Dental Needles
7.30.1.9 Terumo Spinal Needles
7.30.1.10 SurGuard Safety Insulin Syringes
7.30.1.11 Terumo Insulin Syringes
7.30.1.12 Thinpro Insulin Syringes for Retail Customers
7.31 UltiMed, Inc.
7.31.1 UltiCare Insulin Syringes
7.31.2 UltiCare Pen Needles
7.32 Unilife Medical Solutions Ltd.
7.32.1 Unilife's Solutions
7.32.2 Prefilled Syringes from Unilife
7.32.3 Clinical (Hypodermic) Syringes from Unilife
7.32.4 Unilife's Self Injection Systems
7.32.4.1 Auto-Injectors
7.32.4.2 Unilife's Auto-Infusors
7.32.5 Unilife's Products
7.32.5.1 Unifill Syringe
7.32.5.2 Unitract 1 mL Syringes
7.32.5.3 Unifill Select
7.32.5.4 Unifill Rita
7.32.5.5 Unifill EZMix syringes
7.32.5.6 Unilife Autoinfusor
7.33 Vetter Pharma-Fertigung GmbH & Co.
7.33.1 Vetter Services and Solutions
7.33.2 Vetter's Dual-Chamber Technology
7.34 Vita Needle Company, Inc.
7.34.1 Disposable Stainless Steel Needle Blunts from Vita Needle
7.34.2 Teflon Dispensing Needles
7.34.3 Vita Needle's Polypropylene Needles
7.34.4 Vita Needle's Taper Tip Needles
7.35 West Pharmaceutical Services, Inc.
7.35.1 West's Business Segments
7.35.1.1 Packaging Systems Segment
7.35.1.2 Delivery Systems Segment
7.35.2 West's Syringe Products
7.35.2.1 The West ConfiDose Autoinjector System
7.35.2.2 West's Prefillable Syringes
7.35.2.3 Plungers
7.35.2.4 Needle Shields
7.35.2.5 Tip Caps
7.36 Wuxi Yushou Medical Appliances Co., Ltd.
7.37 Ypsomed Holding AG
7.37.1 Future Trends in Self Medication: Ypsomed Holding's Perceptions
7.37.2 ServoPen Insulin Pen
7.37.3 YpsoPen Twist
7.37.4 UnoPen
7.37.5 LyoTwist
7.37.6 YpsoMate
7.37.7 Mylife OmniPod Insulin Patch Pump

Appendix 1: Sharps Safety Products
Appendix 1.1: Air Bubble Removal Devices
Appendix 1.2: Allergy Syringes
Appendix 1.3: Amniocentesis Trays
Appendix 1.4: Ampoule Breaker
Appendix 1.5: Apheresis Needles
Appendix 1.6: Arterial Blood Gas Syringes
Appendix 1.7: Arterial Line Draw
Appendix 1.8: Automated Filling of IV Syringe Doses
Appendix 1.9: Bifurcated Needles
Appendix 1.10: Bleeding Time Devices
Appendix 1.11: Blood Collection
Appendix 1.12: Blood Culture Bottles
Appendix 1.13: Blood Donor Needles
Appendix 1.14: Blood Slide Preparation Devices
Appendix 1.15: Blood Transfer Devices
Appendix 1.16: Blunt Suture Needles
Appendix 1.17: Bone Marrow Biopsy Needle Kits
Appendix 1.18: Bone Marrow Collection Systems
Appendix 1.19: Capillary Blood Collection
Appendix 1.20: Carpuject Safety Needle Systems
Appendix 1.21: Cataract Safety Scalpel
Appendix 1.22: Catheter Securement Devices
Appendix 1.23: Chemo Waste Sharp Containers
Appendix 1.24: Closed Arterial Sampling
Appendix 1.25: Closed Venous Sampling
Appendix 1.26: Closed System Antineoplastic Systems
Appendix 1.27: Cord Clamping Products
Appendix 1.28: Cord Blood Collection Products
Appendix 1.29: Dental Anesthesia—Automatic
Appendix 1.30: Dental Anesthesia Syringe
Appendix 1.31: Epidural Needle
Appendix 1.32: Epidural Continuous Infusion Trays
Appendix 1.33: Fascia Closing Device
Appendix 1.34: Finger Protection
Appendix 1.35: Finger-Stick Sampling
Appendix 1.36: Flu Syringe
Appendix 1.37: Puncture Indicator Gloves
Appendix 1.38: HeelStick Lancets
Appendix 1.39: Hemodialysis Catheter Needles
Appendix 1.40: Huber Needles
Appendix 1.41: Injection Therapy
Appendix 1.42: Insulin Injection
Appendix 1.43: Introducer Needles
Appendix 1.44: IV Access
Appendix 1.45: IV Catheter
Appendix 1.46: Knee Tap Syringe
Appendix 1.47: Lancet
Appendix 1.48: Lumbar Puncture Kits
Appendix 1.49: Magnetic Instrument Transfer
Appendix 1.50: Magnetic Sharps Retriever
Appendix 1.51: Medical Fluid Waste Disposal
Appendix 1.52: Medication Reconstitution
Appendix 1.53: Microfiltration
Appendix 1.54: Minimally-Invasive Laproscopic Suturing Device
Appendix 1.55: Myelogram Saftey Trays
Appendix 1.56: Needle Counter
Appendix 1.57: Needle Disintegration Products
Appendix 1.58: Needle-free IV Systems
Appendix 1.59: Needle-free IV Bag Spike
Appendix 1.60: Needle Parking Device
Appendix 1.61: Neuropathy Screening
Appendix 1.62: Opthalmic Scalpel
Appendix 1.63: Paracentesis, Pneumo Thorax, Thoracentesis Trays
Appendix 1.64: Percutaneous Endoscopic Gastrostomy (PEG)
Appendix 1.65: Pharmacy Safety Trays
Appendix 1.66: PICC Catheter Trays with Safety Components
Appendix 1.67: PICC Introducer
Appendix 1.68: Prefilled Syringes
Appendix 1.69: Pre-procedure Bandages
Appendix 1.70: Puncture-resistant Gloves
Appendix 1.71: Recapping Devices
Appendix 1.72: Scalpels, Retractable
Appendix 1.73: Scalpels, Shielded
Appendix 1.74: Scalpels, Weighted
Appendix 1.75: Scalpel Blade Remover
Appendix 1.76: Scalpel Holder
Appendix 1.77: Segment Sampling Devices
Appendix 1.78: Self-sealing Capillary Tubes
Appendix 1.79: Serum Dispenser
Appendix 1.80: Sharps Containers, Disposable
Appendix 1.81: Sharps Containers, Mail-back
Appendix 1.82: Sharps Containers, Pharmaceutical
Appendix 1.83: Sharps Containers, Reusable
Appendix 1.84: Sharps Securing Device
Appendix 1.85: Skin Stapler
Appendix 1.86: Spinal Trays
Appendix 1.87: Staple Remover
Appendix 1.88: Sternum Closing Device
Appendix 1.89: Striped Syringe for Labeling Safety
Appendix 1.90: Suction Canister System
Appendix 1.91: Surgical Floor Aspirator
Appendix 1.92: Surgical Instrument Transfer Products
Appendix 1.93: Surgical Safety Products
Appendix 1.94: Suture Removal Devices
Appendix 1.95: Syringe Labeling for Safety
Appendix 1.96: Syringe Management System
Appendix 1.97: Temporary Sharps Containers
Appendix 1.98: Topical Anesthetic Device
Appendix 1.99: Transfer Fluid Devices
Appendix 1.100: Tuberculin Syringe
Appendix 1.101: Tympanocentesis Speculum
Appendix 1.102: Umbilical Catheter Tray with Safety Components
Appendix 1.103: Umbilical Line Draw
Appendix 1.104: Urine Sampling and Collection
Appendix 1.105: Vial Access Adapters
Appendix 1.106: Winged Set for Blood Collection
Appendix 1.107: Wound Closure, Glue
Appendix 1.108: Wound Irrigation
Appendix 2: Forces of Change in the U.S. Healthcare
Appendix 2.1: Expanding Coverage under Healthcare Reform
Appendix 2.2: More Coverage under Medicaid
Appendix 2.3: Accountability and Incentives
Appendix 2.4: Ways to Reduce Cost
Appendix 2.5: Better Value for What the Country Spends
Appendix 2.6: Primary Care Shortage
Appendix 2.7: Medicare Modernization Act (MMA)
Appendix 2.8: National Health Expenditure Projections
Appendix 2.9: Prescription Drug Trend
Appendix 2.10: Growth in Specialty
Appendix 2.11: Cost per Day
Appendix 2.12: Increased Utilization
Appendix 2.13: Prescription Benefit Performance and Trend
Appendix 2.14: Possible GDRs of 80% in 2012
Appendix 2.15: Impact of New Brands and Formulations
Appendix 2.16: Pradaxa
Appendix 2.17: OxyContin
Appendix 2.18: Cymbalta
Appendix 2.19: Crestor
Appendix 2.20: Fastest Growing Specialty Line
Appendix 3: A Benchmark for Medical Injectables
Appendix 3.1: Medical Benefit Drug Formulary
Appendix 3.2: Provider Reimbursement
Appendix 3.3: Benefit Design
Appendix 3.4: Oral vs. Intravenous
Appendix 3.5: Distribution Channel Management
Appendix 3.6: Utilization Management
Appendix 3.7: Trend Drivers
Appendix 3.8: Spend Drivers
Appendix 3.9: National Trends
Appendix 3.10: Drug Pipeline
Appendix 4: The Use of Medicines in the U.S.
Appendix 4.1: Spending on Medicines
Appendix 4.2: Volume of Medicines Consumed
Appendix 4.3: Patient Payment for Medicines
Appendix 4.4: Comparison of 2010 vs. 2009 Spending
Appendix 4.5: Changes in Usage and Spending in Major Therapy Areas
Appendix 4.6: Increased Real Spending in 2010
Appendix 4.7: Spending Growth in 2010
Appendix 4.8: Volume Growth Performance
Appendix 4.9: Total Prescription Volume Growth
Appendix 4.10: Shift toward Medicare Part D and Medicaid
Appendix 4.11: Decline in Copayments and Shift to Generics
Appendix 4.12: Spending Changes in Five Major Segments
Appendix 4.13: Decline in Volume Growth
Appendix 4.14: Spending on Protected Brands
Appendix 4.15: Spending on New Brands
Appendix 4.16: Brand Launches in 2010
Appendix 4.17: Spending on Products before Generic Entry
Appendix 4.18: Total Generic Market Share
Appendix 4.19: Spending in Leading Therapy Classes
Appendix 4.20: Oncology Growth by Area
Appendix 4.21: Respiratory Growth by Area
Appendix 4.22: Growth of Lipid Regulators
Appendix 4.23: Growth in Antipsychotic Spending
Appendix 5: Syringe Needle Terminology
Appendix 6: Medication Errors and Syringe Safety
Appendix 6.1: Injectable Medication Errors
Appendix 6.2: Frequency of Syringe Usage
Appendix 6.3: Labeling Injectable Medications
Appendix 6.4: Challenges of Labeling
Appendix 6.5: Benefits of a Write-On Stripe
Appendix 6.6: Nurses Influence on Selection of Sharp Devices
Appendix 6.7: Needlestick Injuries
Appendix 6.8: Prevention of Needlestick Injuries
Appendix 6.9: Protection from Needlestick Injuries

INDEX OF FIGURES

Figure 2.1: Filling and Packaging of Prefilled Syringes
Figure 2.2: Prefilled Syringes with Safety Devices
Figure 4.1: Most Common Instances when Needlesticks Occur
Figure 4.2: Needlestick Injuries in Massachusetts with Healthcare Facilities with Safety vs. Standard Syringes, 2002-2008
Figure 4.3: Indicative Pricing Chart for Safety Features
Figure 5.1: Syringe Sizes Required for Injectable Drugs
Figure 5.2: Global Market for Disposable Syringes, 2011-2018
Figure 5.3: Global Market for Disposable Syringes by Segmentation, 2011
Figure 5.4: Global Market for Safety Syringes by Segmentation, 2011
Figure 5.5: Combined Market for Drug Delivery Syringe Devices, 2010-2015
Figure 5.6: Breakdown of U.S. Syringe Market
Figure 5.7: Types of Safety Syringes used in the U.S. Healthcare Facilities
Figure 5.8: U.S. Adoption of Safety Syringes, 2011-2018
Figure 5.9: The Total Disposable Syringe Market in the U.S., 2011-2018
Figure 5.10: The U.S. Market for Safety Syringes, 2011-2018
Figure 5.11: European Overall Market for Disposable Syringes, 2011-2018
Figure 5.12: European Adoption of Safety Syringes, 2011-2018
Figure 5.13: Market Share of Prefilled Syringes by Geography
Figure 5.14: Number of Drugs in the Core Therapeutic Areas for Prefilled Syringes
Figure 5.15: Global Market for Prefilled Syringes, 2011-2018
Figure 5.16: Steady Growth of Global Prefilled Syringe Unit Consumption, 2011-2018
Figure 5.17: World vs. U.S. Market for Prefilled Syringes, 2011-2018
Figure 5.18: Consumption of Prefilled Syringes by Pharmaceutical Company
Figure 5.19: Pharmaceutical Consumption of Prefilled Syringes by Therapeutic Drug Class
Figure 5.20: Global Market for Prefilled Pain Management Drugs, 2011-2018
Figure 5.21: Global Sales of Enbrel in Prefilled Syringes, 2005-2011
Figure 5.22: Global Market for Prefilled Psoriasis Drugs, 2011-2018
Figure 5.23: Global Market for Prefilled Anemia Drugs, 2011-2018
Figure 5.24: Global Market for Prefilled Insulin, 2011-2018
Figure 5.25: Growth of Prefilled Insulin Devices and Decline of Vials and Syringes, 1994-2010
Figure 5.26: Global Market for Oncology Drugs in Prefilled Syringes, 2011-2018
Figure 5.27: Global Market for Multiple Sclerosis (MS) Drugs in Prefilled Syringes, 2011-2018
Figure 5.28: Market Share for Multiple Sclerosis Drugs in Prefilled Syringes by Company, 2011
Figure 5.29: Global Market for Arthritis Drugs in Prefilled Syringes, 2011-2018
Figure 5.30: Percent Growth of Vaccines in Prefilled Syringes, 2011-2018
Figure 5.31: Market Share for Vaccines in Prefilled Syringes by Company, 2011
Figure 5.32: Market Share for Anti-Coagulants in Prefilled Syringes by Company, 2011
Figure 5.33: Market Share for Anti-Inflammatory Drugs in Prefilled Syringes, 2011
Figure 5.34: Market Share for Hematology Drugs in Prefilled Syringes by Company, 2011
Figure 5.35: Market Share for Obstetrics Drugs in Prefilled Syringes by Company, 2011
Figure 5.36: Global Market for Insulin Pen, 2011-2018
Figure 5.37: Global Market for Auto-Injectors/Auto-Infusors, 2011-2018
Figure 5.38: U.S. Leaders in Insulin Pumps, 2011
Figure 5.39: Market for Self-Injection Syringes, 2011-2018
Figure 6.1: Global Market for Conventional Injectables, 2011-2018
Figure 6.2: Global Market for Injection, Infusion and Vascular Access Devices, 2011-2018
Figure 6.3: Global Burden of Diabetes, 2010-2030
Figure 6.4: Global Market for Insulin Delivery Devices, 2009-2016
Figure 6.5: Insulin Delivery Devices Worldwide Market Shares, 2011
Figure 6.6: Insulin Consumption in Selected Countries, 2000 and 2010
Figure 6.7: Growth of Modern Insulin, 1994-2010
Figure 6.8: Growth of Modern Insulin Delivery Systems, 1994-2010
Figure 6.9: Global Insulin Value Market Share, 2011
Figure 6.10: Global Insulin Volume Market Share, 2011
Figure 6.11: Treatment of Diabetes in the U.S.: Share of Patients by Treatment Class, 2011
Figure 6.12: U.S. Treatment of Diabetes: Share of Insulin by Type, 2011
Figure 6.13: U.S. Treatment of Diabetes: Share of Incretin by Type, 2011
Figure 6.14: U.S. Diabetes Care Market by Treatment Class, 2006-2011
Figure 6.15: U.S. Insulin Volume Market by Segment, 2006-2011
Figure 6.16: U.S. Insulin Value Market Growth, 2006-2011
Figure 6.17: Modern Insulin and Device Penetration in the U.S. Market, 2006-2011
Figure 6.18: U.S. Total Insulin Volume Market Share by Company, 2011
Figure 6.19: U.S. Total Insulin Value Market Share by Company, 2011
Figure 6.20: U.S. Total Short-Acting Insulin Market Share (Volume) by Company, 2011
Figure 6.21: U.S. Total Premix Insulin Market Share (Volume) by Company, 2011
Figure 6.22: U.S. Total Long-Acting Insulin Market Share (Volume) by Company, 2011
Figure 6.23: European Diabetes Care Market by Treatment Class, 2006-2011
Figure 6.24: European Diabetes Care Market Share by Company, 2011
Figure 6.25: European Distribution of People with Diabetes Initiating TDZ, DPP-IV, GLP-1 and Insulin
Figure 6.26: E.U. Insulin Market by Segment, 2006-2011
Figure 6.27: E.U. Modern Insulin Market Share by Company, 2011
Figure 6.28: Chinese Diabetes Care Market by Treatment Class, 2006-2011
Figure 6.29: Chinese Diabetes Care Value Market Share by Company, 2011
Figure 6.30: Chinese Insulin Market by Segment, 2006-2011
Figure 7.1: BD Medicals Business Performance by Segment, 2011
Figure 7.2: Performance of BD Medical Segment, 2011
Figure 7.3: Performance of BD Diagnostics Segment, 2011
Figure 7.4: Performance of BD Biosciences, 2011
Figure 7.5: BD's Geographic Performance, 2011
Figure 7.6: Share of Bioject's Business by Customer, 2010
Figure 7.7: Bioject's Business by Product Line, 2010
Figure 7.8: Bioject's Business by Geography, 2010
Figure 7.9: Catalent's Revenue by Segment, 2011
Figure 7.10: Retractable Technologies' Business by Geography, 2010
Figure 7.11: Smiths' Market by Segment, 2011
Figure 7.12: Insulin Market by Geography, 2009-2015
Figure 7.13: Global Insulin Market by Manufacturers, 2009-2015
Figure A2.1: Estimated Health Insurance Coverage without Health Reform, 2019
Figure A2.2: Estimated Health Insurance Coverage with Reform, 2019
Figure A2.3: Projected National Health Expenditures under ACA, 2009-2019
Figure A2.4: Projected Annual Growth Rates in National Health Expenditures (NHE), 2009-2019
Figure A2.5: Projected Percentage of Insured, 2009-2019
Figure A2.6: Average Wholesale Price (AWP) Inflation, 2008-2010
Figure A2.7: Prescription Spend Distribution, 2005 and 2015
Figure A3.1: Formularies in Place by Plan Size
Figure A3.2: Therapeutic Classes with a Medical Formulary Currently in Place
Figure A3.3: Rebates Received by Size of Health Plan
Figure A3.4: Therapeutic Classes with Rebates
Figure A3.5: Reimbursement Approach
Figure A3.6: Reimbursement Approach by Size of Plan
Figure A3.7: Development of Drug Reimbursement Strategies
Figure A3.8: Duration of Current Reimbursement Strategies
Figure A3.9: Payors Who Capitate or Use Case Rates
Figure A3.10: Membership Subject to Contribution
Figure A3.11: Member Cost Reimbursements Overall
Figure A3.12: Member Cost Reimbursement by Plan Size
Figure A3.13: Member Contribution Parity
Figure A3.14: Genomic Test Requirements
Figure A3.15: Screening/Prevention Programs in Place
Figure A3.16: HEDIS Prevention Programs Established
Figure A3.17: Member Compliance by Screening Program
Figure A3.18: End-of Life Programs Provided
Figure A3.19: End-of-Life Program Coverage
Figure A3.20: Payors Monitoring Member Participation
Figure A3.21: Level of Employer Engagement by Plan Size
Figure A3.22: Percentage of Medical Claims Billed
Figure A3.23: Managing Utilization of Products
Figure A3.24: Cancer's Subjected to Medical Utilization Tools
Figure A3.25: Specific Prior Authorization Criteria
Figure A3.26: Post-HOC Edits Conducted
Figure A3.27: Implementation of Edits
Figure A3.28: Spend by Provider Specialty
Figure A4.1: Growth in Spending on Medicines, 2001-2010
Figure A4.2: Total Real Spending, 2006-2010
Figure A4.3: Real Spending per Capita, 2006-2010
Figure A4.4: Volume Growth in Injectable Standard Units, 2006-2010
Figure A4.5: Prescription Volume Growth, 2001-2010
Figure A4.6: Shift Toward Medicare Part D and Medicaid Between 2006 and 2010
Figure A4.7: Protected Brand Price Spending Growth, 2006-2010
Figure A4.8: New Brand Spending, 2006-2010
Figure A4.9: Spending on Products before Generic Entry, 2006-2010
Figure A4.10: Generic Share of Total Prescriptions, 2006-2010
Figure A4.11: Spending in Leading Therapy Classes, 2010
Figure A4.12: Oncology Growth by Area, 2006-2010
Figure A4.13: Respiratory Growth by Area, 2006-2010
Figure A6.1: Timing of Needlestick Injuries

INDEX OF TABLES

Table 2.1: Components of a Prefilled Syringe
Table 2.2: Key Advantages of Prefilled Syringes
Table 2.3: Insulin Pens Available in the U.S.
Table 2.4: Types of Insulins Used in Cartridges
Table 2.5: Aspects of Insulin Pens to be considered
Table 2.6: User Characteristics of Insulin Pens
Table 5.1: Selected Injectable Therapeutics and Vaccines Available in the U.S. Market
Table 5.2: Key Advantages of Prefilled Syringes
Table 5.3: Pharmaceutical Share of Key Prefilled Therapeutic Market
Table 5.4: Key Prefilled Products
Table 5.5: Biotech Blockbusters Available in Vials and Prefilled Syringes
Table 6.1: Alternative Modes of Insulin Delivery
Table 6.2: Types of Insulin Used in Pump Therapy
Table 6.3: Insulin Pumps Assessed by AFB TECH Company, 2004 and 2008
Table 7.1: Albert David's Syringes with Needles
Table 7.2: Albert David's Needles
Table 7.3: Syringes from Alshifa
Table 7.4: BD's Auto-Disable Syringes
Table 7.5: Insulin Syringes from BD
Table 7.6: BD's Allergy Syringes
Table 7.7: BD's Tuberculin Syringes
Table 7.8: BD's Sterile, Single-Use Syringes and Needles
Table 7.9: BD's Safety-Lok Safety-Syringes
Table 7.10: BD's Safety Glide Syringes
Table 7.11: BD's Eclipse Syringes
Table 7.12: BD's Integra Syringe
Table 7.13: BD's PosiFlush Prefilled Syringes
Table 7.14: Bard's Piston Syringes
Table 7.15: Bard's Bulb Syringes and Trays, 2009
Table 7.16: Angiographic Syringes from Coeur
Table 7.17: CT Syringes from Coeur
Table 7.18: HMD's Dispovan Insulin Syringes
Table 7.19: HMD's Single-Use Needles
Table 7.20: HMD's Single-Use Syringes
Table 7.21: Hi-Tech Single-Use Syringes
Table 7.22: Hi-Tech's Single-Use Insulin Syringes
Table 7.23: HCM's Contract Manufacturing Categories
Table 7.24: Syringes from IMS
Table 7.25: PCA Syringes from IMS
Table 7.26: Phytonadione Injection USP from IMS
Table 7.27: Lidocaine Prefilled Syringes from IMS
Table 7.28: Life-Shield's Syringe Products
Table 7.29: Estimated Market for MedPro's Targeted Product Sectors
Table 7.30: Autopen Products from Owen Mumford
Table 7.31: Autoject Products from Owen Mumford
Table 7.32: Unifine Products from Owen Mumford
Table 7.33: Retractable Technologies' VanishPoint Syringes
Table 7.34: Smiths' Pro Fixed Needle TB Syringes
Table 7.35: Smiths' Needle-Pro with Needle Protection Devices
Table 7.36: Smiths' Needle-Pro Syringe and Needle with Needle Protection Device
Table 7.37: Smiths' Needle-Pro Needle Protection Device for Insulin Injections
Table 7.38: Smiths' Needle-Pro Fixed Needle Insulin Syringe
Table 7.39: SurGard2 Syringes with Safety Needle
Table 7.40: Terumo's SurGard2 Safety Needles
Table 7.41: Terumo's Hypodermic Needles
Table 7.42: Terumo's Hypodermic Syringes without Needle
Table 7.43: Terumo's Tuberculin Syringes
Table 7.44: Terumo's Hypodermic Syringes with Needle
Table 7.45 Terumo's SurSaver 1 cc Syringes with Low Dead Space
Table 7.46: Terumo's Dental Needles
Table 7.47: Terumo's Spinal Needles
Table 7.48: Terumo's SurGard Safety Insulin Syringes
Table 7.49: Terumo's Insulin Syringes
Table 7.50: Thinpro Insulin Syringes
Table 7.51: UltiMed's UltiCare Insulin Syringes
Table 7.52: UltiCare Pen Needles
Table 7.53: Vita Needle's Stainless Steel Needle Blunts
Table 7.54: Vita Needle's Teflon Dispensing Needles
Table 7.55: Vita Needles Polypropylene Needles
Table 7.56 Vita Needle's Taper Tip Needles
Table A2.1: Top Five Specialty Categories, 2010
Table A2.2: Top Ten Therapeutic Categories, 2010
Table A2.3: Blockbuster Brands Going Generic, 2011-2013
Table A2.4: Projected Generic Launches, 2011-2015
Table A3.1: Common Cancer Types under Formulary
Table A3.2: Drug Volume Distributed to Patients via Physician Office
Table A3.3: Utilization Management Tools by Class
Table A3.4: Management Tools for Common Therapies
Table A3.5: Top Medical Injectable Concerns, 2011
Table A3.6: Top 25 Injectable Drugs, 2009
Table A3.7: Portion of Members who Received a Medical Injectable
Table A3.8: Spend by Key Therapeutic Class
Table A3.9: Top Five Diagnosis Codes
Table A3.10: FDA-approved Injectable Drugs, 2010
Table A4.1: Brand Launches by Type, 2010

- Abbott Laboratories
- Albert David Limited
- Alshifa Medical Syringes Manufacturing Company Ltd.
- Althea Technologies, Inc.
- Avitro, Inc.
- Baxter International, Inc.
- Becton, Dickinson and Company (BD)
- Boston Scientific Corporation
- B. Braun
- Bioject Medical Technologies, Inc.
- Catalent Pharma Solutions, Inc.
- C.R. Bard, Inc.
- Coeur, Inc.
- Covidien Ltd.
- Henke-Sass, Wolf GmbH
- Hindustan Syringes & Medical Devices, Ltd. (HMD)
- Hi-Tech Medical Products Ltd.
- Hyaluron Contract Manufacturing
- International Medication System Ltd.
- Life-Shield Products, Inc.
- Merit Medical Systems, Inc.
- Milestone Scientific
- Novo Nordisk A/S
- Owen Mumford Ltd.
- Plas-Pak Industries, Inc.
- Retractable Technologies, Inc.
- Revolutions Medical Corporation
- Safety Syringes, Inc.
- Smiths Medical International/Medex, Inc.
- Specialized Health Products International, Inc.
- Star Syringe Ltd.
- Terumo's Medical Corporation
- UltiMed, Inc.
- Unilife Medical Solutions, Ltd.
- Vetter Pharma-Fertigung GmbH & Co., KG
- Vita Needle Company, Inc.
- West Pharmaceutical Services, Inc.
- Wuxi Yushou Medical Appliances Co., Ltd.
- Ypsomed Holding AG
- The Medical House PLC (TMH)